Open comparative, randomized controlled clinical study of a new immunostimulating bacterial lysate in the prophylaxis of upper respiratory tract infections

Arzneimittel-Forschung/Drug Research

Volumn 55, Issue 5, 2005, Pages 276-281

  Macchi, Alberto ^a   Delia Vecchia, Laura ^a  

^a OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Bacterial lysate, polivalent mechanical; Immunostimulant; Ismigen , clinical trial, upper respiratory tract infections; Upper respiratory tract infections, prevention, recurrent

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM LYSATE; IMMUNOSTIMULATING AGENT; ISMIGEN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG SAFETY; FEMALE; HUMAN; IMMUNOSTIMULATION; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

EID: 20344373438     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296857     Document Type: Article

References (15)

1. th edition, McGraw-Hill, New York (August 2004)
2. th edition, McGraw-Hill, New York (August 2004)
3. Lanzilli, G., Falchetti, R., Tricarico, M. et al., In vitro effects of an Immunostimulating Bacterial Lysate on human lymphocyte function. Int. J. Immunopathol. Pharmacol. (Accepted for publication)
4. Rossi, S., Tazza, R., Efficacy and Safety of a New Immunostimulating Bacterial Lysate in the Prophylaxis of Acute Lower Respiratory Tract Infections. Arzneim.-Forsch./Drug Res. 54, 50 (2004)
5. Tricarico, D., Varricchio, A., D'Ambrosio, S. et al., Prevention of Recurrent Upper Respiratory Tract Infections in a Community of Cloistered Nuns using a New Immunostimulating Bacterial Lysate. Arzneim.-Forsch./Drug Res 54, 57 (2004)
6. Collet, J. P., Shapiro, S., Ernst. P. et al., and the PARI-IS Study Steering Committee and Research Group. Effect of an immunostimulating agent on acute exacerbations and hospitalisation in patients with chronic obstructive pulmonary diseases. Am. J. Resp. Crit. Care Med. 156, 1713 (1997)
7. Macchi, A., Spriano G., Efficacia e tollerabilità di un nuovo vaccino immunostimolante, ottenuto per lisi batterica meccanica, nella profilassi degli episodi infettivi delle alte vie respiratorie. 89° Congresso Nazionale della Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale. 20-22 May 2002, Colli del Tronto, AP (Italy)
8. Jara-Perez, Y, Berber, A., Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked placebo-controlled clinical trial. Clin. Ther. 22, 748 (2000)
9. Orcel, B., Oral immunisation with bacterial extract for protection against acute bronchitis, in elderly institutionalized patients with chronic bronchitis. Eur. Respir. J. 7, 446 (1994)
10. Gutienez-Tarango, M.D., Berber, A., Safety and efficacy of two courses of OM85 BV in the prevention of respiratory tract infections in children during 12 months. Chest 119, 1742 (2001)
11. Palmieri, G., Immunomodulating effects of a bacterial lysate in elderly subjects. Curr. Ther. Res. 42, 1194 (1987)
12. Czerkinsky, C., Anjuere, E, Meghee, J. R. et al., Mucosal immunity and tolerance: Relevance to vaccine development. Immunol. Rev. 170, 197 (1999)
13. th ERS Annual Congress, 27 September 2003, Vienna (Austria)
14. Melioli, G. G., Evidences of preclinical and clinical efficacy of the Polyvalent Mechanical Bacterial Lysate (PMBL). Fifth European Congress of Otorhinolaringology and Neck Surgery, September 12-16, 2004, Rhodes (Greece)
15. Rossi, G. A., Peri, C., Raynal, M. E. et al., Naturally occurring immune response against bacteria commonly involved in upper respiratory tract infections: analysis of the antigen-specific salivary IgA levels. Immunol. Lett. 86, 85 (2003)